MiniMed Group
MMED
MiniMed Group (MMED) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Jefferies | Initiated Coverage | Hold | $22.00 | Oct 12, 2026 |
| Mizuho | Maintained | Outperform | $28.00 from $26.00 | Oct 8, 2026 |
| Barclays | Initiated Coverage | Equal-Weight | $22.00 | Oct 7, 2026 |
| Truist Securities | Initiated Coverage | Buy | $29.00 | Sep 24, 2026 |
| Morgan Stanley | Maintained | Overweight | $21.00 from $19.00 | Sep 3, 2026 |
| B of A Securities | Maintained | Buy | $28.00 from $24.00 | Sep 2, 2026 |
| Mizuho | Maintained | Outperform | $26.00 from $21.00 | Sep 2, 2026 |
| UBS | Maintained | Buy | $28.00 from $25.00 | Sep 2, 2026 |
| Wells Fargo | Maintained | Overweight | $26.00 from $22.00 | Sep 2, 2026 |
| Evercore ISI Group | Maintained | Outperform | $27.00 from $20.00 | Sep 2, 2026 |
| Citigroup | Maintained | Buy | $26.00 from $23.00 | Sep 2, 2026 |
| BTIG | Maintained | Buy | $28.00 from $25.00 | Sep 1, 2026 |
| UBS | Initiated Coverage | Buy | $25.00 | Jul 28, 2026 |
| Wells Fargo | Maintained | Overweight | $22.00 from $26.00 | Jun 4, 2026 |
| B of A Securities | Maintained | Buy | $20.00 from $27.00 | May 18, 2026 |
| Benchmark | Initiated Coverage | Buy | $20.00 | May 12, 2026 |
| Barclays | Initiated Coverage | Overweight | $26.00 | Apr 1, 2026 |
| Mizuho | Initiated Coverage | Outperform | $21.00 | Mar 31, 2026 |
| Piper Sandler | Initiated Coverage | Neutral | $16.00 | Mar 31, 2026 |
| Evercore ISI Group | Initiated Coverage | Outperform | $20.00 | Mar 31, 2026 |
Frequently asked questions
What is the latest analyst rating on MMED?
On Oct 12, 2026, Jefferies initiated coverage of MiniMed Group at Hold with a price target of $22.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.